Browsing: Duke-nus

Recent research from Singapore questions whether two doses of COVID-19 vaccine are sufficient for children, exploring the necessity of booster shots amid variant concerns. Since the start of the COVID-19 pandemic, extensive research in epidemiology, clinical practice, and virology has greatly increased our understanding of the virus and its impact on human health.

Log In or Register as a healthcare professional to read the full article.

This research exemplifies Duke-NUS’s collaborative spirit, combining expertise across disciplines to push the boundaries of medical science. Professor Patrick Tan, Senior Vice-Dean for Research at Duke-NUS, said: “This is a sterling example of how different research programmes within the School come together to tap their various expertise to advance medical knowledge and improve patients’ lives. The team’s valuable insights may one day translate into a new treatment option to control tumour growth or even offer a cure for cancer.”

The Duke-NUS research team, collaborating with Duke University and the National University of Singapore, conducted a preclinical comparison between nasal and subcutaneous administration of the COVID-19 vaccine. Their findings were published in eBioMedicine. It revealed that the intranasal route not only induces a strong mucosal antibody response but also enhances long-term mucosal and systemic immune protection.